ID: MRFR/HC/6306-HCR | February 2021 | Region: Global | 90 pages
Global Aortic Aneurysm Market is expected to register a healthy CAGR over the forecast period. The market held a market value of USD 2,357.6 million in 2017 and is projected to grow at a CAGR of 8.4% during the forecast period. The aortic aneurysm is a condition in which the aorta is enlarged (dilated) to greater than 1.5 times of normal size that leads to rupturing of the artery resulting in internal bleeding. Aortic aneurysm has two types such as an abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). An abdominal aortic aneurysm is an aneurysm in the part of the aorta that passes through the abdomen whereas thoracic aortic aneurysm is an aortic aneurysm that presents mainly in the thorax. Factors characterizing the market growth are rising prevalence of tobacco smoking in the developed and developing countries, worldwide growing elderly population coupled with the increasing burden of cardiovascular diseases, favorable reimbursement scenarios for surgical treatment of aortic aneurysms, and mounting technological advancements in products. On the flip side, the presence of low reimbursement rates in the developing region and high cost of aortic aneurysm treatment and devices are anticipated to impede the market growth during the forecast period.
The global aortic aneurysm market has been segmented into type, product, treatment, end user, and region.
By type, the market has been segmented into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). The abdominal aortic aneurysm segment would command the market over the forecast period. This is due to its increased disease incidence as it is more common in the lower abdominal part, and most of the cases of AAA occur at the infrarenal or juxtarenal part of the lower abdomen. Collectively, the number of aortic aneurysm repairs performed for infrarenal and juxtarenal are higher than a thoracic aortic aneurysm.
On the basis of product, the market has been divided into stent-grafts, catheters, and others.
By treatment, the market has been classified into endovascular aneurysm repair (EVAR) and open surgical repair (OSR).
Based on end user, the market has been categorized into hospitals and clinics, ambulatory surgery centers (ASCs), and others.
The global aortic aneurysm market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The aortic aneurysm market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.
The European aortic aneurysm market has been segmented into Western Europe and Eastern Europe. The Western Europe aortic aneurysm market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The aortic aneurysm market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The aortic aneurysm market in the Middle East & Africa has been segmented into the Middle East and Africa.
Few of the spearheads in the global aortic aneurysm market are Medtronic plc, Cook Medical, Terumo Medical Corporation, Microport Scientific Corporation, MAQUET Holding B.V. & Co. KG, Endologix, Inc., W. L. Gore & Associates, Lombard Medical Limited, JOTEC AG (CryoLife, Inc.), and Cardinal Health, Inc.
Source: White Papers, Company Presentations, Annual Reports, and MRFR Analysis
Frequently Asked Questions (FAQ) :
Aortic aneurysm market was valued at USD 2,357.6 million in 2017.
The market is expected to exhibit a solid 8.4% CAGR over the forecast period.
The increasing prevalence of cardiovascular diseases and the increasing prevalence of smoking are the major drivers for the aortic aneurysm market.
The Americas and Europe are likely to dominate the global aortic aneurysm market over the forecast period.
Leading players in the aortic aneurysm market include Medtronic, Cook Medical, Microport Scientific Corporation, Endologix, Cardinal Health, Lombard Medical Ltd., L. Gore & Associates, and Terumo Medical Corporation, among others.
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.